Michaels Aya Y, Washburn Erin E, Pocius Katherine D, Benson Carol B, Doubilet Peter M, Carusi Daniela A
Departments of Radiology (A.Y.M., C.B.B., D.A.C.) and Obstetrics and Gynecology (E.E.W., K.D.P., P.M.D.), Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts USA.
J Ultrasound Med. 2015 Apr;34(4):595-9. doi: 10.7863/ultra.34.4.595.
The purpose of this study was to determine the outcome of cesarean scar pregnancies diagnosed during the first trimester.
We retrospectively identified all cesarean scar implantation pregnancies diagnosed by sonography before 14 weeks' gestation between 2000 and 2012 at our institution. We reviewed the patients' sonograms and medical records and recorded sonographic findings and pregnancy outcomes.
Thirty-four cases met study entry criteria. Ten patients presented with no embryonic cardiac activity, of whom 7 underwent interventions, and 3 were expectantly managed. One of the former 7 and none of the latter 3 required hysterectomy for bleeding. Among the 24 patients with embryonic cardiac activity, 8 were managed expectantly: 5 (62.5%) ultimately delivered a live-born neonate, 3 (60.0%) of whom required hysterectomy due to placenta accreta; and 3 had fetal demise. Sixteen of the 24 underwent interventions, 2 opting for gravid hysterectomy (10 and 11 weeks' gestation, respectively) and 14 treated by a minimally invasive method: intrasac potassium chloride injection (3 cases); intrasac potassium chloride injection plus intramuscular methotrexate (4 cases); sonographically guided dilation and curettage (6 cases); and laparascopic resection (1 case). None of the latter 14 subsequently required hysterectomy.
If a woman has a first-trimester diagnosis of a cesarean scar implantation pregnancy and embryonic cardiac activity is present, expectant management offers the possibility of delivering a live-born neonate (62.5% in our study) but carries a substantial likelihood of hysterectomy at delivery due to placenta accreta (37.5% in our study), whereas minimally invasive therapy that interrupts the pregnancy largely eliminates the need for hysterectomy.
本研究旨在确定孕早期诊断的剖宫产瘢痕妊娠的结局。
我们回顾性地确定了2000年至2012年在我院妊娠14周前经超声诊断的所有剖宫产瘢痕妊娠病例。我们查看了患者的超声图像和病历,并记录了超声检查结果和妊娠结局。
34例符合研究纳入标准。10例患者未见胚胎心搏,其中7例接受了干预,3例采取期待治疗。前7例中的1例和后3例中的0例因出血需要行子宫切除术。在24例有胚胎心搏的患者中,8例采取期待治疗:5例(62.5%)最终分娩出活产新生儿,其中3例(60.0%)因胎盘植入需要行子宫切除术;3例发生胎儿死亡。24例中的16例接受了干预,2例选择妊娠子宫切除术(分别为妊娠10周和11周),14例采用微创方法治疗:羊膜腔内注射氯化钾(3例);羊膜腔内注射氯化钾加肌内注射甲氨蝶呤(4例);超声引导下刮宫术(6例);腹腔镜切除术(1例)。后14例中无一例随后需要行子宫切除术。
如果一名妇女在孕早期被诊断为剖宫产瘢痕妊娠且存在胚胎心搏,期待治疗有可能分娩出活产新生儿(我们的研究中为62.5%),但由于胎盘植入,分娩时行子宫切除术的可能性很大(我们的研究中为37.5%),而中断妊娠的微创治疗在很大程度上消除了行子宫切除术的必要性。